TY - JOUR
T1 - Gastrointestinal Laser Endoscopy—Future Horizons
AU - GOSTOUT, CHRISTOPHER J.
PY - 1990
Y1 - 1990
N2 - The laser, especially the neodymium:yttrium-aluminum-garnet device, has been a dominant influence on the development of gastrointestinal therapeutic endoscopy. More than 2,000 such procedures were performed in the first 5 years of experience with laser endoscopy at the Mayo Clinic. The major areas for future development are (1) the control of acute and chronic gastrointestinal bleeding, (2) the palliation of malignant gastrointestinal neoplasms, and (3) the management of benign and malignant obstructive lesions of the biliary tract. Refinements in laser devices, delivery systems, and techniques such as photodynamic therapy will be needed to achieve more selective tissue destruction. Improvements in the new adjunctive endoscopic methods of electronic (video) endoscopy and ultrasonography may enhance evolving laser applications by more accurately identifying diseased tissues and guiding their destruction.
AB - The laser, especially the neodymium:yttrium-aluminum-garnet device, has been a dominant influence on the development of gastrointestinal therapeutic endoscopy. More than 2,000 such procedures were performed in the first 5 years of experience with laser endoscopy at the Mayo Clinic. The major areas for future development are (1) the control of acute and chronic gastrointestinal bleeding, (2) the palliation of malignant gastrointestinal neoplasms, and (3) the management of benign and malignant obstructive lesions of the biliary tract. Refinements in laser devices, delivery systems, and techniques such as photodynamic therapy will be needed to achieve more selective tissue destruction. Improvements in the new adjunctive endoscopic methods of electronic (video) endoscopy and ultrasonography may enhance evolving laser applications by more accurately identifying diseased tissues and guiding their destruction.
UR - http://www.scopus.com/inward/record.url?scp=0025234308&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0025234308&partnerID=8YFLogxK
U2 - 10.1016/S0025-6196(12)60950-1
DO - 10.1016/S0025-6196(12)60950-1
M3 - Article
C2 - 2185383
AN - SCOPUS:0025234308
SN - 0025-6196
VL - 65
SP - 509
EP - 517
JO - Mayo Clinic proceedings
JF - Mayo Clinic proceedings
IS - 4
ER -